Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Haematologica|May 1, 1994
Fludarabine in untreated and previously treated B-CLL patients: a report on efficacy and toxicityM Spriano, M Clavio, P Carrara, et al.Journal of Experimental & Clinical Cancer Research : CR|December 16, 2006
Monitoring molecular response by BCR-ABL, JH and WT-1 in Ph+ all treated with imatinib containing regimen: preliminary report of two casesM Miglino, R Varaldo, N Colombo, et al.British Journal of Haematology|April 1, 1990
Ras activation in myelodysplastic syndromes: clinical and molecular study of the chronic phase of the diseaseC Melani, A Haliassos, J C Chomel, et al.Journal of Experimental & Clinical Cancer Research : CR|May 24, 2001
Detection of minimal residual disease in B-lymphoproliferative disorders: a three step SSCP-PCR methodM Miglino, R Grasso, D Pietrasanta, et al.Journal of Experimental & Clinical Cancer Research : CR|August 4, 2001
Cost of de novo acute myeloid leukemia induction therapy in adults: analysis of EORTC-GIMEMA AML10 and FLANG regimensM Clavio, S Quintino, B Masoudi, et al.Haematologica|July 17, 2001
Molecular analysis of patients with relapsed or refractory intermediate-high grade non-Hodgkin's lymphoma with bone marrow infiltration undergoing peripheral blood progenitor cell transplantationM Miglino, G Santini, R Grasso, et al.Mycopathologia|March 15, 2008
A case of Cunninghamella bertholettiae rhino-cerebral infection in a leukaemic patient and review of recent published studiesE Righi, C G Giacomazzi, V Lindstrom, et al.International Journal of Laboratory Hematology|December 9, 2009
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipientsA Ballestrero, G Cirmena, A Dominietto, et al.Journal of Experimental & Clinical Cancer Research : CR|November 23, 2001
Lymphoplasmacytic lymphoma/immunocytoma: towards a disease-targeted treatment?M Clavio, S Quintino, C Venturino, et al.Leukemia & Lymphoma|June 28, 2001
First line therapy with fludarabine combinations in 42 patients with either post myelodysplastic syndrome or therapy related acute myeloid leukaemiaM Clavio, S Gatto, G Beltrami, et al.Pageof 3